17-76391404-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_022066.4(UBE2O):āc.3418A>Gā(p.Asn1140Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000388 in 1,613,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022066.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE2O | NM_022066.4 | c.3418A>G | p.Asn1140Asp | missense_variant | 18/18 | ENST00000319380.12 | NP_071349.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE2O | ENST00000319380.12 | c.3418A>G | p.Asn1140Asp | missense_variant | 18/18 | 1 | NM_022066.4 | ENSP00000323687.6 | ||
UBE2O | ENST00000587127.1 | c.1960A>G | p.Asn654Asp | missense_variant | 10/10 | 1 | ENSP00000468498.1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 250754Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135722
GnomAD4 exome AF: 0.000401 AC: 586AN: 1461172Hom.: 0 Cov.: 36 AF XY: 0.000384 AC XY: 279AN XY: 726898
GnomAD4 genome AF: 0.000263 AC: 40AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2022 | The c.3418A>G (p.N1140D) alteration is located in exon 18 (coding exon 18) of the UBE2O gene. This alteration results from a A to G substitution at nucleotide position 3418, causing the asparagine (N) at amino acid position 1140 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at